About GeneTex
GeneTex is a Healthcare company based in Hsinchu (Taiwan) founded in 1997. GeneTex is a manufacturer and supplier of bioreagents for life science research. The company has 11 employees. Its chief executive is Joel Baseman. Its website genetex.com draws about 49 thousand monthly visits. GeneTex offers products and services including Primary Antibodies, Secondary Antibodies, HistoMAX Antibodies, ELISA Kits, and Proteins and Peptides. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is GENETEX INC. Its competitors include Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
GeneTex was founded in 1997 and is headquartered in Hsinchu, Taiwan. Operations focus on the life science sector, where primary antibodies, secondary antibodies, proteins, peptides, lysates, slides, serum, reagents, research kits, and isotype controls are produced and distributed. These products support research in areas such as cancer, cell biology, epigenetics, immunology, infectious disease, metabolism, neuroscience, signal transduction, stem cell development, and zebrafish biology.
- Headquarters Hsinchu, Taiwan
- Employees 11
- SectorsHealthcare
- Website genetex.com
- Social LinkedIn X Facebook
- Legal Name Genetex Inc
- Latest Funding Round$4.3M (USD), Unspecified
Mar 2012
- Employee Count11
Products & Services of GeneTex
GeneTex offers a comprehensive portfolio of products and services, including Primary Antibodies, Secondary Antibodies, HistoMAX Antibodies, ELISA Kits, and Proteins and Peptides.
Antibodies for detecting specific proteins in research assays
Antibodies enhancing detection in immunoassays
Optimized antibodies for immunohistochemistry applications
Kits for enzyme-linked immunosorbent assays
Proteins and peptides for biological studies
Funding Insights of GeneTex
- Total Rounds 1
- Last Round Unspecified — $4.3M
- First Round $4.3M
(Mar 2012)
All 1 funding rounds of GeneTex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2012 | $4.3M | Unspecified | – | – | – |
People of GeneTex
1 people are tracked at GeneTex (1 in leadership); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Joel Baseman | CEO | Leadership |
Complete people profiles for GeneTex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GeneTex
2 dated milestones of GeneTex across 15 years, from founding to its latest funding, stage changes and deals.
- Founded GeneTex is founded.
- Funding First funding round of $4.3M.
Competitors of GeneTex
GeneTex has 10 listed competitors in our database, 6 of them funded. They include Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| mabtech.com | 1986 | Nacka, Sweden | – | – | Antibodies and immunoassay kits are developed for research applications. | |
| ybiologics.com | 2007 | Daejeon, South Korea | $42.1M | – | Developer of antibodies for the treatment of multiple diseases | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | – | Monoclonal antibody technology and products are developed by Epitomics. | |
| abtis.co.kr | 2016 | Suwon-si, South Korea | $4.5M | – | Technology for antibody-drug conjugation is provided by AbTis. | |
| opmbiosciences.com | 2013 | Pudong, China | $14.42M | – | Antibody and vaccine culture media products are developed. | |
| vectorlabs.com | 1976 | Burlingame, United States | – | – | Labeling and detection reagents immunohistochemistry studies and other life science research applications | |
| bioventix.com | 2003 | Farnham, United Kingdom | – | 16 | Sheep monoclonal antibody manufacturer | |
| leinco.com | 1992 | St. Louis, United States | – | – | Manufacturer of antibodies, proteins, reagents, and kits for life science research |
Detailed competitors of GeneTex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GeneTex
The website of GeneTex (genetex.com) receives about 48.7K visits a month.
- Monthly visits48.7K
▼ 7.8% vs previous month
Websites whose visitors overlap most with GeneTex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abcam.com | 100% | 602.8K | #91,958 | View details | |
| novusbio.com | 94% | 199.6K | #232,152 | View details | |
| scbt.com | 92% | 444.3K | #138,937 | View details | |
| avivasysbio.com | 87% | – | #1,515,411 | View details | |
| cellsignal.com | 86% | 488.2K | #114,694 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for GeneTex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as GeneTex (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genetex
Complete news archive for GeneTex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GeneTex
GeneTex was founded in 1997 and raised its 1st funding round 15 years after it was founded.
GeneTex is headquartered in Hsinchu, Taiwan.
Joel Baseman is the current CEO of GeneTex.
GeneTex has 11 employees.
GeneTex was founded in 1997 and is headquartered in Hsinchu, Taiwan. Operations focus on the life science sector, where primary antibodies, secondary antibodies, proteins, peptides, lysates, slides, serum, reagents, research kits, and isotype controls are produced and distributed. These products support research in areas such as cancer, cell biology, epigenetics, immunology, infectious disease, metabolism, neuroscience, signal transduction, stem cell development, and zebrafish biology.
GeneTex's top competitors include Sino Biological, GenScript and Y-Biologics.
GeneTex offers Primary Antibodies, Secondary Antibodies, HistoMAX Antibodies, ELISA Kits, and Proteins and Peptides.
GeneTex operates through Genetex Inc.